Tidal Investments LLC Increases Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

Tidal Investments LLC increased its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI) by 158.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 46,159 shares of the real estate investment trust’s stock after purchasing an additional 28,326 shares during the quarter. Tidal Investments LLC’s holdings in Omega Healthcare Investors were worth $1,879,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in OHI. State Street Corp increased its holdings in shares of Omega Healthcare Investors by 0.9% in the third quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust’s stock worth $502,228,000 after buying an additional 114,085 shares during the period. Geode Capital Management LLC grew its position in Omega Healthcare Investors by 3.1% during the 3rd quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust’s stock worth $261,589,000 after acquiring an additional 192,465 shares during the last quarter. FMR LLC increased its stake in Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock worth $171,625,000 after purchasing an additional 380,626 shares during the period. Daiwa Securities Group Inc. lifted its position in Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock valued at $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Omega Healthcare Investors by 6.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust’s stock valued at $155,893,000 after purchasing an additional 240,006 shares during the period. 65.25% of the stock is owned by institutional investors.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $38.99 on Tuesday. Omega Healthcare Investors, Inc. has a fifty-two week low of $27.53 and a fifty-two week high of $44.42. The stock’s 50 day simple moving average is $40.37 and its two-hundred day simple moving average is $38.02. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. The stock has a market cap of $10.52 billion, a price-to-earnings ratio of 28.67, a PEG ratio of 1.22 and a beta of 0.98.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a $0.67 dividend. The ex-dividend date was Monday, November 4th. This represents a $2.68 annualized dividend and a yield of 6.87%. Omega Healthcare Investors’s payout ratio is 197.06%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on OHI shares. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets upgraded shares of Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 target price for the company in a report on Monday, December 9th. Berenberg Bank started coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Finally, Mizuho increased their price objective on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a report on Thursday, December 5th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and a consensus target price of $40.18.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at $4,025,000. This represents a 36.19 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.